Why Hercules Capital Stock Is Back On Watch
Hercules Capital (HTGC) has moved higher after analyst estimate revisions pointed to a more optimistic business outlook, with expectations for steady earnings and revenue in the upcoming quarterly report.
See our latest analysis for Hercules Capital.
Recent trading shows Hercules Capital’s share price gaining 2.23% in the latest session and 9.72% over 90 days, although the year to date share price return is down 17.39% while the 5 year total shareholder return sits at 58.21%. This suggests long term holders have still seen meaningful gains despite recent pressure.
If Hercules Capital’s recent move has you thinking about where else growth and income stories might emerge, this is a good moment to widen your search with 20 top founder-led companies
With Hercules Capital trading at $15.58 and data pointing to both an intrinsic value gap and a discount to analyst targets, the key question is whether the recent optimism leaves room for upside or if the stock already reflects future growth.
Most Popular Narrative: 19.5% Undervalued
Against Hercules Capital’s last close at $15.58, the most followed narrative anchors on a fair value of $19.36. This frames the current discount as valuation-driven rather than sentiment-only.
Ongoing successful capital raises (including the $350M investment-grade notes and upsized credit facility) ensure low funding costs and ample liquidity, enabling Hercules to compete aggressivley for quality deals and sustain strong portfolio growth, bolstering future revenue.
Want to see the full playbook behind that $19.36 figure? Revenue build, margin reset, and a higher future earnings multiple all sit at the center of this narrative. The tension between growth, dilution and required return is where the story becomes more complex.
Result: Fair Value of $19.36 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Hercules Capital’s story could change if competition in venture lending squeezes yields, or if concentrated exposure to technology and life sciences leads to outsized credit losses.
Find out about the key risks to this Hercules Capital narrative.
Next Steps
With Hercules Capital presenting both appealing upside arguments and clear areas of concern, now is a good time to review the numbers, pressure test the assumptions, and weigh the trade off between potential reward and risk for yourself through the 5 key rewards and 2 important warning signs
Looking For More Investment Ideas Beyond Hercules Capital?
If Hercules Capital is back on your radar, do not stop there. Widen your opportunity set with a few focused stock ideas tailored to different investing goals.
- Target quality at a discount by scanning companies screened as potential value opportunities with 44 high quality undervalued stocks
- Strengthen your income stream by hunting for companies with higher yields and payout resilience using 8 dividend fortresses
- Dial up resilience by focusing on companies flagged for sturdier finances and lower risk profiles through the 71 resilient stocks with low risk scores
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com